Biotech Startups
10,023 companies tagged Biotech, with their investors and founders.
Madison Vaccines Inc. (MVI) develops immunotherapies and therapeutic vaccines for prostate cancer, designed to be combined with standard-of-care treatments and checkpoint inhibitors across metastatic and non-metastatic stages. Its therapies target patients at all stages of prostate cancer to delay disease progression and enhance the effectiveness of PD-1 and AR axis inhibitors.
0 investors
0 investors
0 investors
0 investors
A company focused on addressing malaria through research and solutions aimed at reducing the disease's health and economic burden.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Marius Pharmaceuticals develops therapies for hormonal and metabolic health, with a focus on treating testosterone deficiency and hypogonadism in men and women. The company works in the pharmaceutical and biotech space, offering research-based treatments aimed at improving hormone balance and metabolic function.
0 investors
0 investors
0 investors
MarvelBiome is a clinical-stage biotechnology company developing Live Biotherapeutic Products through engineered bacterial consortia designed to treat disease-specific conditions. The company focuses on microbiome-based treatments for patients.
0 investors
0 investors
Mati Therapeutics develops a non-invasive sustained drug delivery platform, the Evolute Punctal Plug Delivery System, for treating ocular diseases such as glaucoma. The device delivers medication over an extended period, removing the need for patients to administer eye drops.
0 investors
Matinas BioPharma develops a Lipid Nano-Crystal (LNC) drug delivery platform that enables oral, intracellular delivery of small molecules and oligonucleotides. Its lead product MAT2203 is an amphotericin B formulation, alongside discovery programs in oncology and inflammation.
0 investors
0 investors
0 investors
0 investors
Maverix Oncology develops conditionally activated small molecule therapeutics for cancer treatment, led by a team of oncologists and cancer scientists with experience in drug discovery and development.
0 investors